NCT01713530 - A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin | Biotech Hunter

Enrollment

274

Participants

Timeline

Start Date

February 21, 2013

Primary Completion Date

January 9, 2014

Study Completion Date

January 9, 2014

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec/insulin aspart

Dose individually adjusted. For subcutaneous (s.c, under the skin) administration twice a day.

DRUG

insulin degludec

Dose individually adjusted. For subcutaneous (s.c, under the skin) administration once daily.

DRUG

insulin aspart

Dose individually adjusted. For subcutaneous (s.c, under the skin) administration with the main meals 2-4 times daily in accordance with local labelling.

Trial Locations (51)

1090

Novo Nordisk Investigational Site, Vienna

1130

Novo Nordisk Investigational Site, Vienna

2212

Novo Nordisk Investigational Site, Kongsvinger

2317

Novo Nordisk Investigational Site, Hamar

2340

Novo Nordisk Investigational Site, Mödling

4011

Novo Nordisk Investigational Site, Stavanger

4021

Novo Nordisk Investigational Site, Linz

4604

Novo Nordisk Investigational Site, Kristiansand

5010

Novo Nordisk Investigational Site, Salzburg

6020

Novo Nordisk Investigational Site, Innsbruck

8036

Novo Nordisk Investigational Site, Graz

14033

Novo Nordisk Investigational Site, Caen

15236

Novo Nordisk Investigational Site, Pittsburgh

17019

Novo Nordisk Investigational Site, La Rochelle

20852

Novo Nordisk Investigational Site, Rockville

25000

Novo Nordisk Investigational Site, Constantine

25401

Novo Nordisk Investigational Site, Martinsburg

27408

Novo Nordisk Investigational Site, Greensboro

28472

Novo Nordisk Investigational Site, Whiteville

31000

Novo Nordisk Investigational Site, Oran

34000

Novo Nordisk Investigational Site, Montpellier

34070

Novo Nordisk Investigational Site, Montpellier

34741

Novo Nordisk Investigational Site, Kissimmee

37660

Novo Nordisk Investigational Site, Kingsport

44800

Novo Nordisk Investigational Site, Saint-Herblain

45429

Novo Nordisk Investigational Site, Kettering

46254

Novo Nordisk Investigational Site, Indianapolis

49620

Novo Nordisk Investigational Site, Buckley

60607

Novo Nordisk Investigational Site, Chicago

69200

Novo Nordisk Investigational Site, Vénissieux

71200

Novo Nordisk Investigational Site, Le Creusot

75230

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

77024

Novo Nordisk Investigational Site, Houston

78224

Novo Nordisk Investigational Site, San Antonio

78681

Novo Nordisk Investigational Site, Round Rock

78731

Novo Nordisk Investigational Site, Austin

85295

Novo Nordisk Investigational Site, La Roche-sur-Yon

91345

Novo Nordisk Investigational Site, Mission Hills

92111

Novo Nordisk Investigational Site, San Diego

94904

Novo Nordisk Investigational Site, Greenbrae

98405

Novo Nordisk Investigational Site, Tacoma

70461-4231

Novo Nordisk Investigational Site, Slidell

08844-1225

Novo Nordisk Investigational Site, Hillsborough

08648

Novo Nordisk Investigational Site, Lawrenceville

08755-8050

Novo Nordisk Investigational Site, Toms River

44281-9236

Novo Nordisk Investigational Site, Wadsworth

Unknown

Novo Nordisk Investigational Site, Algiers

Novo Nordisk Investigational Site, Annaba

0586

Novo Nordisk Investigational Site, Oslo

NO-2020

Novo Nordisk Investigational Site, Skedsmokorset